Skip to main content
. 2019 May 2;2019:6201764. doi: 10.1155/2019/6201764

Figure 4.

Figure 4

Correlation between KMO IRS and pathologic malignancy in CMTs. The expression of the KMO protein was analyzed by immunohistochemistry and scored by immunoreactive score (IRS). KMO IRS showed a statistically significant association with tumor malignancy (P < 0.05). KMO IRS in malignant CMTs was significantly higher than that in benign CMTs (∗∗∗P < 0.001).